Europe

Hair loss in AGA – new study by CompLife

Androgenetic Alopecia (AGA) is a progressive hair loss type affecting up to 80% of men and 50% of women. COMPLIFE performed a new study to test the effectiveness of a client’s product on this disease and published it on the “Journal of Cosmetology & Trichology.” Their Methods include: phototrichogram(Anagen, telogen and hair density were estimated in a target area and automatically calculated by TrichoScan® software), global photography assessment , and self assessment questionnaire.

Read the complete study on their website and contact them for further infos.

👉 Find out more about CompLife expertise on the 🥼 clinical testing platform : here

 

CONTACT

www.complifegroup.com

info@complifegroup.com

 

Recent Posts

ZOOM#32 – Deep dive into the evaluation of neurosensory claims by Skinobs

Dear Readers, The Skinobs team would like to apologise sincerely to Faiza Hussain, Co-Founder and…

Acheless wearable device via CES 2025

Acheless is an essential wearable device for modern society, where digital living is commonplace. To…

Sensory Studies: Linking consumer and sensory data to develop optimal products by Syres

Linking consumer data with sensory data is an essential step in formulating products that accurately…